Juniper Pharmaceuticals, Inc.
Juniper Pharmaceuticals, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2004, the company has established itself as a leader in developing innovative therapeutics, particularly in women's health and reproductive medicine. With a focus on unique drug delivery systems, Juniper's core products include specialised formulations that address unmet medical needs, setting them apart in a competitive market. The company has achieved significant milestones, including successful partnerships and advancements in clinical trials, which have bolstered its market position. Juniper Pharmaceuticals is recognised for its commitment to improving patient outcomes through cutting-edge research and development, making it a notable entity in the biopharmaceutical landscape.
DitchCarbon Score
How does Juniper Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Juniper Pharmaceuticals, Inc.'s score of 32 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Juniper Pharmaceuticals, Inc.'s reported carbon emissions
Juniper Pharmaceuticals, Inc., headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. Additionally, the company has not outlined any formal reduction targets or climate commitments, which limits the ability to assess their environmental impact or sustainability initiatives. In the context of the pharmaceutical industry, many companies are increasingly focusing on reducing their carbon footprints and committing to science-based targets to mitigate climate change. However, without specific data or commitments from Juniper Pharmaceuticals, it is challenging to evaluate their position in this regard.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Juniper Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
